Aveo Pharmaceuticals (AVEO) 1.50 $AVEO Midday G
Post# of 64072
Posted On: 03/08/2015 5:22:02 PM
Aveo Pharmaceuticals (AVEO) 1.50 $AVEO
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 11:45AM CST
SSH: 4.03 (-1.32), ONCY: 0.90 (-0.15), LTM: 66.32 (+8.65), LEDS: 1.03 (-0.13), CLDN: 24.00 (+2.54), AXN: 1.49 (+0.37), EXAS: 24.50 (+2.07), DRRX: 1.64 (+0.30), DRAD: 4.88 (+0.48), BLRX: 2.12 (-0.69), GENE: 4.86 (-1.39), OREX: 7.10 (-0.91), ICEL: 6.61 (+0.99), BORN: 1.23 (-0.32), DMD: 5.95 (+0.70), AVEO: 1.50 (+0.08), CALA: 14.67 (+1.36), MTL: 1.53 (-0.30), CKP: 11.37 (-2.06), ERII: 2.79 (-0.47)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 8:15AM CST
NGL: 27.04 (-1.94), FNSR: 22.23 (+1.90), SSH: 4.03 (-1.32), YY: 57.76 (+2.59), CNAT: 6.05 (-0.54), ASTI: 1.43 (-0.02), CLDN: 24.00 (+2.54), AXN: 1.49 (+0.37), VMEM: 3.59 (-0.40), BLRX: 2.12 (-0.69), GENE: 4.86 (-1.39), OREX: 7.10 (-0.91), SKUL: 10.40 (-0.67), CALA: 14.67 (+1.36), AVEO: 1.50 (+0.08), MSO: 4.96 (+0.09), GALE: 1.88 (-0.12), CKP: 11.37 (-2.06)
AVEO Pharmaceuticals misses by $0.06
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 5:15AM CST
AVEO: 1.50 (+0.08)
Regulators Want Drug Companies to Be Honest About FDA
at The Street - Wed Mar 04, 12:08PM CST
The Securities and Exchange Commission's top cop wants drug companies to be more transparent with investors about their dealings with the U.S. Food and Drug Administration.
HEB: 0.25 (-0.01), AVEO: 1.50 (+0.08), AMPE: 5.88 (+0.02), SNY: 47.42 (-0.94)
Market Maker Surveillance Report. TTI, ABTL, AVEO, EYES, CLNE, XIN, Winning Stocks With Lowest Price Friction For Friday, February 27th 2015
M2 - Mon Mar 02, 5:29AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 5214 companies with "abnormal" market making, 2975 companies with positive Friction Factors and 3319 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Friday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. TETRA Technologies Inc (NYSE:TTI), Autobytel Inc (NASDAQ:ABTL), Aveo Pharmaceuticals Inc (NASDAQ:AVEO), VISION TWENTY-ONE INC (NASDAQ:EYES), Clean Energy Fuels Corp (NASDAQ:CLNE), iShares MSCI EAFE Index (CAD-Hedged) (NYSE:XIN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
EYES: 17.44 (+0.37), ABTL: 14.46 (-0.31), XIN: 3.11 (-0.08), AVEO: 1.50 (+0.08), TTI: 5.38 (-0.14), CLNE: 5.47 (-0.07)
Aveo Oncology to host conference call to discuss trial results
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 6:38AM CST
AVEO: 1.50 (+0.08)
Seeking Baupost: The Pangs Of Value Investing - Part 1
Matthew Finston - at Seeking Alpha - Mon Feb 16, 9:28AM CST
ELOS: 12.22 (+0.20), MU: 28.50 (-0.78), AR: 36.89 (-0.24), PBF: 29.59 (-1.10), OCN: 8.91 (+0.24), NCQ: 0.68 (-0.02), LNG: 76.91 (-1.50), KOS: 8.28 (+0.01), KIN: 6.68 (-0.20), VSAT: 64.50 (-0.25), KERX: 12.56 (-0.63), NG: 3.26 (-0.19), BXE: 2.99 (-0.06), AOI: 0.95 (-0.03), EBAY: 59.87 (+0.79), ALDW: 19.04 (-0.06), BYD: 13.92 (-0.04), AVEO: 1.50 (+0.08), SEMI: 24.40 (+0.49), VRTV: 50.05 (-0.17), THRX: 19.60 (-0.26), TBPH: 20.23 (-0.52), IMOS: 23.28 (-0.27)
CAR-T Vs ErbB3 Market Opportunity Comparison
Decision Analytics - Seeking Alpha - Wed Jan 21, 12:32PM CST
CAR-T therapy, also known as "Adoptive Immunotherapy", has been the result of significant investor excitement recently. One look at the stock charts for JUNO and KITE is illustrative of this optimism. While this enthusiasm may be warranted,...
MACK: 12.38 (-0.10), BLUE: 113.14 (+0.91), ZIOP: 13.38 (-0.43), BLCM: 24.48 (+0.13), KITE: 66.41 (+1.44), AVEO: 1.50 (+0.08), JUNO: 52.84 (+0.81), GSK: 46.73 (-0.87), REGN: 422.13 (-6.82), NVS: 97.46 (-1.49)
AVEO to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Mon Jan 12, 5:30AM CST
AVEO Oncology (NASDAQ:AVEO) today announced that Michael P. Bailey, president and chief executive officer, will present at the 33rd Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2015 at 12:00PM (PT) in San Francisco.
JPM: 60.89 (-1.11), AVEO: 1.50 (+0.08)
New medical chief at Aveo
Seeking Alpha - at Seeking Alpha - Fri Jan 09, 7:06AM CST
AVEO: 1.50 (+0.08)
AVEO Names Michael N. Needle, M.D., As Chief Medical Officer
Business Wire - Fri Jan 09, 5:30AM CST
AVEO Oncology (NASDAQ:AVEO) today announced the appointment of Michael N. Needle, M.D., to the position of Chief Medical Officer. In this role, Dr. Needle, a board certified hematologist/oncologist, will take a leadership role in evaluating clinical development strategies for advancement of the Company's partnered and proprietary pipeline programs. He will report to Michael Bailey, AVEO's president and chief executive officer.
AVEO: 1.50 (+0.08)
AVEO Receives Confirmation of Eligibility for Submission of a Tivozanib Marketing Authorization Application to the European Medicines Agency
Business Wire - Thu Jan 08, 5:30AM CST
AVEO Oncology (NASDAQ:AVEO) today announced that it has received written confirmation from the European Medicine Agency (EMA) that tivozanib is eligible for submission of an application for a European Union Marketing Authorization under the Agency's centralized procedure. Confirmation of eligibility was given in response to the submission of a letter of intent enabling the Company to evaluate the opportunity for submitting a Marketing Authorization Application (MAA) for tivozanib with the EMA for the treatment of renal cell carcinoma (RCC). Tivozanib is an oral, potent, selective inhibitor of vascular endothelial growth factor tyrosine kinase inhibitor (VEGF TKI) with a long half-life and activity against all three VEGF receptors. Tivozanib has previously been granted orphan drug designation in Europe for the treatment of RCC.
AVEO: 1.50 (+0.08)
Aveo names new chief amid restructuring
Seeking Alpha - at Seeking Alpha - Wed Jan 07, 8:19AM CST
AVEO: 1.50 (+0.08)
AVEO Announces Executive Transition and Corporate Restructuring
Business Wire - Wed Jan 07, 5:30AM CST
--Company to Eliminate Internal Research Function to Align Corporate Resources with the Company's Future Strategic Plans
AVEO: 1.50 (+0.08)
Aveo up on (old) news of Klarman stake
Seeking Alpha - at Seeking Alpha - Thu Dec 18, 11:00AM CST
OPHT: 53.19 (-0.29), AVEO: 1.50 (+0.08)
The New Baupost Biotech Picks
Matthew Finston - at Seeking Alpha - Mon Dec 15, 8:53AM CST
BIIB: 417.63 (-7.98), FWP: 22.81 (-0.12), MRK: 56.84 (-1.14), AVEO: 1.50 (+0.08), IDIX: 24.50 (+0.05), ATRA: 28.31 (-0.44), THRX: 19.60 (-0.26), TBPH: 20.23 (-0.52), PRTK: 31.54 (+1.73), KIN: 6.68 (-0.20), KERX: 12.56 (-0.63)
Tracking Seth Klarman's Baupost Group Holdings - Q3 2014 Update
John Vincent - at Seeking Alpha - Mon Nov 17, 9:14AM CST
OCN: 8.91 (+0.24), KOS: 8.28 (+0.01), KIN: 6.68 (-0.20), VSAT: 64.50 (-0.25), RFMD: 16.59 (-0.35), EBAY: 59.87 (+0.79), TQNT: 27.55 (-0.77), IDIX: 24.50 (+0.05), SEMI: 24.40 (+0.49), VRTV: 50.05 (-0.17), THRX: 19.60 (-0.26), TBPH: 20.23 (-0.52), IMOS: 23.28 (-0.27), ELOS: 12.22 (+0.20), MU: 28.50 (-0.78), AR: 36.89 (-0.24), NCQ: 0.68 (-0.02), PBF: 29.59 (-1.10), LNG: 76.91 (-1.50), ATRA: 28.31 (-0.44), KERX: 12.56 (-0.63), NG: 3.26 (-0.19), AOI: 0.95 (-0.03), FWP: 22.81 (-0.12), BYD: 13.92 (-0.04), ALDW: 19.04 (-0.06), SUNE: 22.64 (-0.53), MRK: 56.84 (-1.14), AVEO: 1.50 (+0.08), AIG: 56.00 (+0.39)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 11:45AM CST
SSH: 4.03 (-1.32), ONCY: 0.90 (-0.15), LTM: 66.32 (+8.65), LEDS: 1.03 (-0.13), CLDN: 24.00 (+2.54), AXN: 1.49 (+0.37), EXAS: 24.50 (+2.07), DRRX: 1.64 (+0.30), DRAD: 4.88 (+0.48), BLRX: 2.12 (-0.69), GENE: 4.86 (-1.39), OREX: 7.10 (-0.91), ICEL: 6.61 (+0.99), BORN: 1.23 (-0.32), DMD: 5.95 (+0.70), AVEO: 1.50 (+0.08), CALA: 14.67 (+1.36), MTL: 1.53 (-0.30), CKP: 11.37 (-2.06), ERII: 2.79 (-0.47)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 8:15AM CST
NGL: 27.04 (-1.94), FNSR: 22.23 (+1.90), SSH: 4.03 (-1.32), YY: 57.76 (+2.59), CNAT: 6.05 (-0.54), ASTI: 1.43 (-0.02), CLDN: 24.00 (+2.54), AXN: 1.49 (+0.37), VMEM: 3.59 (-0.40), BLRX: 2.12 (-0.69), GENE: 4.86 (-1.39), OREX: 7.10 (-0.91), SKUL: 10.40 (-0.67), CALA: 14.67 (+1.36), AVEO: 1.50 (+0.08), MSO: 4.96 (+0.09), GALE: 1.88 (-0.12), CKP: 11.37 (-2.06)
AVEO Pharmaceuticals misses by $0.06
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 5:15AM CST
AVEO: 1.50 (+0.08)
Regulators Want Drug Companies to Be Honest About FDA
at The Street - Wed Mar 04, 12:08PM CST
The Securities and Exchange Commission's top cop wants drug companies to be more transparent with investors about their dealings with the U.S. Food and Drug Administration.
HEB: 0.25 (-0.01), AVEO: 1.50 (+0.08), AMPE: 5.88 (+0.02), SNY: 47.42 (-0.94)
Market Maker Surveillance Report. TTI, ABTL, AVEO, EYES, CLNE, XIN, Winning Stocks With Lowest Price Friction For Friday, February 27th 2015
M2 - Mon Mar 02, 5:29AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 5214 companies with "abnormal" market making, 2975 companies with positive Friction Factors and 3319 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Friday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. TETRA Technologies Inc (NYSE:TTI), Autobytel Inc (NASDAQ:ABTL), Aveo Pharmaceuticals Inc (NASDAQ:AVEO), VISION TWENTY-ONE INC (NASDAQ:EYES), Clean Energy Fuels Corp (NASDAQ:CLNE), iShares MSCI EAFE Index (CAD-Hedged) (NYSE:XIN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
EYES: 17.44 (+0.37), ABTL: 14.46 (-0.31), XIN: 3.11 (-0.08), AVEO: 1.50 (+0.08), TTI: 5.38 (-0.14), CLNE: 5.47 (-0.07)
Aveo Oncology to host conference call to discuss trial results
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 6:38AM CST
AVEO: 1.50 (+0.08)
Seeking Baupost: The Pangs Of Value Investing - Part 1
Matthew Finston - at Seeking Alpha - Mon Feb 16, 9:28AM CST
ELOS: 12.22 (+0.20), MU: 28.50 (-0.78), AR: 36.89 (-0.24), PBF: 29.59 (-1.10), OCN: 8.91 (+0.24), NCQ: 0.68 (-0.02), LNG: 76.91 (-1.50), KOS: 8.28 (+0.01), KIN: 6.68 (-0.20), VSAT: 64.50 (-0.25), KERX: 12.56 (-0.63), NG: 3.26 (-0.19), BXE: 2.99 (-0.06), AOI: 0.95 (-0.03), EBAY: 59.87 (+0.79), ALDW: 19.04 (-0.06), BYD: 13.92 (-0.04), AVEO: 1.50 (+0.08), SEMI: 24.40 (+0.49), VRTV: 50.05 (-0.17), THRX: 19.60 (-0.26), TBPH: 20.23 (-0.52), IMOS: 23.28 (-0.27)
CAR-T Vs ErbB3 Market Opportunity Comparison
Decision Analytics - Seeking Alpha - Wed Jan 21, 12:32PM CST
CAR-T therapy, also known as "Adoptive Immunotherapy", has been the result of significant investor excitement recently. One look at the stock charts for JUNO and KITE is illustrative of this optimism. While this enthusiasm may be warranted,...
MACK: 12.38 (-0.10), BLUE: 113.14 (+0.91), ZIOP: 13.38 (-0.43), BLCM: 24.48 (+0.13), KITE: 66.41 (+1.44), AVEO: 1.50 (+0.08), JUNO: 52.84 (+0.81), GSK: 46.73 (-0.87), REGN: 422.13 (-6.82), NVS: 97.46 (-1.49)
AVEO to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Mon Jan 12, 5:30AM CST
AVEO Oncology (NASDAQ:AVEO) today announced that Michael P. Bailey, president and chief executive officer, will present at the 33rd Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2015 at 12:00PM (PT) in San Francisco.
JPM: 60.89 (-1.11), AVEO: 1.50 (+0.08)
New medical chief at Aveo
Seeking Alpha - at Seeking Alpha - Fri Jan 09, 7:06AM CST
AVEO: 1.50 (+0.08)
AVEO Names Michael N. Needle, M.D., As Chief Medical Officer
Business Wire - Fri Jan 09, 5:30AM CST
AVEO Oncology (NASDAQ:AVEO) today announced the appointment of Michael N. Needle, M.D., to the position of Chief Medical Officer. In this role, Dr. Needle, a board certified hematologist/oncologist, will take a leadership role in evaluating clinical development strategies for advancement of the Company's partnered and proprietary pipeline programs. He will report to Michael Bailey, AVEO's president and chief executive officer.
AVEO: 1.50 (+0.08)
AVEO Receives Confirmation of Eligibility for Submission of a Tivozanib Marketing Authorization Application to the European Medicines Agency
Business Wire - Thu Jan 08, 5:30AM CST
AVEO Oncology (NASDAQ:AVEO) today announced that it has received written confirmation from the European Medicine Agency (EMA) that tivozanib is eligible for submission of an application for a European Union Marketing Authorization under the Agency's centralized procedure. Confirmation of eligibility was given in response to the submission of a letter of intent enabling the Company to evaluate the opportunity for submitting a Marketing Authorization Application (MAA) for tivozanib with the EMA for the treatment of renal cell carcinoma (RCC). Tivozanib is an oral, potent, selective inhibitor of vascular endothelial growth factor tyrosine kinase inhibitor (VEGF TKI) with a long half-life and activity against all three VEGF receptors. Tivozanib has previously been granted orphan drug designation in Europe for the treatment of RCC.
AVEO: 1.50 (+0.08)
Aveo names new chief amid restructuring
Seeking Alpha - at Seeking Alpha - Wed Jan 07, 8:19AM CST
AVEO: 1.50 (+0.08)
AVEO Announces Executive Transition and Corporate Restructuring
Business Wire - Wed Jan 07, 5:30AM CST
--Company to Eliminate Internal Research Function to Align Corporate Resources with the Company's Future Strategic Plans
AVEO: 1.50 (+0.08)
Aveo up on (old) news of Klarman stake
Seeking Alpha - at Seeking Alpha - Thu Dec 18, 11:00AM CST
OPHT: 53.19 (-0.29), AVEO: 1.50 (+0.08)
The New Baupost Biotech Picks
Matthew Finston - at Seeking Alpha - Mon Dec 15, 8:53AM CST
BIIB: 417.63 (-7.98), FWP: 22.81 (-0.12), MRK: 56.84 (-1.14), AVEO: 1.50 (+0.08), IDIX: 24.50 (+0.05), ATRA: 28.31 (-0.44), THRX: 19.60 (-0.26), TBPH: 20.23 (-0.52), PRTK: 31.54 (+1.73), KIN: 6.68 (-0.20), KERX: 12.56 (-0.63)
Tracking Seth Klarman's Baupost Group Holdings - Q3 2014 Update
John Vincent - at Seeking Alpha - Mon Nov 17, 9:14AM CST
OCN: 8.91 (+0.24), KOS: 8.28 (+0.01), KIN: 6.68 (-0.20), VSAT: 64.50 (-0.25), RFMD: 16.59 (-0.35), EBAY: 59.87 (+0.79), TQNT: 27.55 (-0.77), IDIX: 24.50 (+0.05), SEMI: 24.40 (+0.49), VRTV: 50.05 (-0.17), THRX: 19.60 (-0.26), TBPH: 20.23 (-0.52), IMOS: 23.28 (-0.27), ELOS: 12.22 (+0.20), MU: 28.50 (-0.78), AR: 36.89 (-0.24), NCQ: 0.68 (-0.02), PBF: 29.59 (-1.10), LNG: 76.91 (-1.50), ATRA: 28.31 (-0.44), KERX: 12.56 (-0.63), NG: 3.26 (-0.19), AOI: 0.95 (-0.03), FWP: 22.81 (-0.12), BYD: 13.92 (-0.04), ALDW: 19.04 (-0.06), SUNE: 22.64 (-0.53), MRK: 56.84 (-1.14), AVEO: 1.50 (+0.08), AIG: 56.00 (+0.39)
(0)
(0)Scroll down for more posts ▼